| Financial Year |
March 31 2023 |
| Monetary Funds |
254,018,224.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
60,000.00 |
| Accounts Receivable |
84,647,714.09 |
| Advances to Suppliers |
960,922.58 |
| Other Receivables |
9,372,287.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
665,078,263.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,112,092.88 |
| Total Current Assets |
1,047,584,011.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,343,196.67 |
| Investment Properties |
172,054,177.39 |
| Fixed Assetes |
423,798,698.82 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,920,055.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,286,120.14 |
| Deferred Income Tax Assets |
11,913,716.19 |
| Other Non-Current Assets |
3,816,349.75 |
| Sub-Total of Non-Current Assets |
761,046,157.59 |
| Total Assets |
1,808,630,169.10 |
| Short-Term Loans |
385,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,130,000.00 |
| Accounts Payable |
52,254,092.52 |
| Accounts Received In Advance |
1,483,390.64 |
| Employee Compensation Payable |
3,228,691.43 |
| Taxes Payable |
23,160,680.25 |
| Interest Payable |
-- |
| Dividend Payable |
4,721,948.93 |
| Other payables |
95,644,074.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,901,422.07 |
| Other Current Liabilities |
130,348.54 |
| Sub-Total of Current Liabilities |
592,563,981.87 |
| Long-term Loans |
104,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
50,000,000.00 |
| Deferred Income Tax Liabilities |
46,362.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
272,743,726.60 |
| Total Liabilities |
865,307,708.47 |
| Paid-In Capital(Or Share Stock) |
684,712,010.00 |
| Capital Surplus |
171,715,797.47 |
| Surplus Reserve |
30,079,583.17 |
| LESS:Treasury Stock |
35,018,028.86 |
| Undistributed Profits |
60,227,061.18 |
| Minority Stockholder's Interest |
64,200,705.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
879,121,754.87 |
| Owner's Equity（Stockholder's Equity） |
943,322,460.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,808,630,169.10 |
